2018 Press Releases
NIH director Francis S. Collins to deliver ENDO 2019 presidential plenary
September 05, 2018
|Contact: Jenni Glenn Gingery
Associate Director, Communications and Media Relations
|Contact: Colleen Williams
Manager, Public Relations
Other prominent speakers include Robert Califf, former FDA Commissioner, and Cori Bargmann, Chan Zuckerberg Initiative
Washington, DC - The Endocrine Society has confirmed the plenary program speaker line-up for ENDO 2019, the world's largest event for endocrine science and medicine. This year features a presidential plenary from Francis S. Collins, M.D., Ph.D., Director of the National Institutes of Health (NIH), the largest supporter of biomedical research in the world. Other noteworthy speakers are Robert Califf, M.D., Duke University School of Medicine and former Food & Drug Administration (FDA) Commissioner, and Cori Bargmann, Ph.D., Rockefeller University and head of the Chan Zuckerberg Initiative’s science work.
Collins is a renowned speaker and talented physician-geneticist noted for his landmark discoveries of disease genes. He’s well known for his leadership of the international Human Genome Project, and he previously served as the director of the NIH’s National Human Genome Research Institute. He will kick off the event with his presidential plenary on translating whole genome data to disease, and the rest of the sessions will cover other innovative topics like neuroendocrinology, big data, nuclear receptor signaling, and hormone science. Here’s a preview of this year’s most cutting-edge sessions:
- Presidential Plenary: Whole Genome Approaches to Unraveling Diseases
Francis S. Collins, M.D., Ph.D., Director, NIH, Bethesda, Md.
- Utilizing Big Data in Science and Clinical Care
Cori Bargmann, Ph.D. Rockefeller University, New York, N.Y., and head of the Chan Zuckerberg Initiative’s science work
Robert Califf, M.D., Duke University School of Medicine, Durham, N.C., and former FDA Commissioner
- Gene Editing and Stem Cells: Using Reproductive Technology for Early Disease Treatment
Juan Carlos Izpisua Belmonte, Ph.D., Salk Institute, La Jolla, Calif.
Marisa Bartolomei, Ph.D., University of Pennsylvania, Philadelphia, Pa.
- Novel Therapeutic Targets in Metabolic Disease and Cancer
Myles Brown, M.D., Dana-Farber Cancer Institute, Boston, Mass.
Peter J. Tontonoz, M.D., Ph.D., University of California-Los Angeles, Los Angeles, Calif.
- Hormone Science to Health: The Endocrine Society Goes to the National Academy of Sciences
Barbara B. Kahn, M.S., M.D., Beth Israel Deaconess Medical Center, Boston, Mass.
Christopher Glass, M.D., Ph.D., University of California - San Diego, La Jolla, Calif.
Mitchell A. Lazar, M.D., Ph.D., University of Pennsylvania
- Targeting Senescent Cells in Aging and Disease
Jan M. van Deursen, Ph.D., Mayo Clinic, Rochester, Minn.
Sundeep Khosla, M.D., Mayo Clinic College of Medicine
ENDO 2019 is being held at the Ernest N. Morial Convention center in New Orleans, La., from March 23-26, 2019. The extensive program will feature advanced endocrine science, poster and Meet-the-Professor sessions, and the newest products and technologies at ENDOExpo.
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.